Moderna Booster May Wane After 6 Months, Company Says - a podcast by time.com

from 2022-01-27T09:05:35

:: ::




Moderna reported today the first data on how well its currently authorized vaccine and booster hold up against the Omicron variant, which quickly dominated new infections around the world after health experts first described the variant last November. The company also announced that it is starting to study its Omicron-specific vaccine.


Further episodes of 301 Moved Permanently

Further podcasts by time.com

Website of time.com